Topic: Biotechnology Sector

Will Wyeth Revolutionize Research at Pfizer?

Last fall, when we visited Wyeth Biotech's campus in Andover, MA, we were blown away by the management's off-the-beaten-path approach to drug development and innovation. Now the storyline has hit an unexpected twist: Officials at ...READ MORE›

Where Are Drug Company Profits Really Going?

The leading trade organization for U.S. drug companies, Pharmaceutical Research and Manufacturers of America, or PhRMA, keeps telling American consumers that the high cost of drugs is due to pricey research and development costs, but ...READ MORE›

Wyeth's Multibillion-dollar Biotech Bet

Drugmaker Wyeth bet billions on biotech, transforming its culture and boosting profits.READ MORE›

PhRMA Chokes International Trade

The Pharmaceutical Research and Manufacturers of America (PhRMA), the leading trade organization for U.S. drug companies, does not want U.S. consumers to have a choice of where they buy their drugs. To keep U.S. consumers from researching foreign markets to find safe drugs at prices as much as three or four times less than in the United States, PhRMA and its members started aggressively shutting down the drug supply to international pharmacies, disabling them from dispensing to U.S. citizens.READ MORE›

Drug Companies Love Profits

It's not too surprising that drug companies love profit and focus on staying in business by creating and marketing new drugs. READ MORE›

A Dose of Change

Face time with Kevin Sharer.READ MORE›

Carol Nacy - Fast 50 2002

6. Set the AgendaREAD MORE›

Genzyme: Good; Genzyme Movie With Han Solo, George of the Jungle: Bad

Genzyme, a leading biotech company that made our Most Innovative Companies list last year, makes its (fictional) film debut today, although, according to a recent Reuters article, the company isn't necessarily thrilled about it. ...READ MORE›

Genzyme at CGI: Global Problem-Solving Gives You a Competitive Advantage

If your corporate social responsibility (CSR) program is ancillary to your corporate strategy, it's on the chopping block--or already in the waste bin. This is especially true in today's economy. On the flip side, you have a chance to ...READ MORE›

Can Protein Sciences Produce a Swine Flu Vaccine in Time? Update: Likely No

As the start of a new school year begins, concerns over H1N1--aka swine flu--are growing. Everyone's waiting to hear when a vaccine will be available, and earlier this summer, the CDC predicted that 120 million doses ... READ MORE›

Why Vaccine Makers Can't Keep Up with the H1N1 Virus

There isn't enough H1N1 vaccine to go around, which is why President Barack Obama declared the outbreak a national emergency over the weekend. Why can't we produce H1N1 vaccines fast enough? Because of chicken eggs.READ MORE›

Blowing the Whistle for the IRS

Most people would just love to get money from the IRS, and not just their regular tax refund, but instead a major chunk of change that would set them up for life.READ MORE›

Brilliant Biotech

Our Innovation Scorecard takes a look at one of the hottest industries around, and comes up with four companies to watch.READ MORE›

Update

Take Two From big molecules spring big deals: Drugmaker Wyeth, which develops large-molecule pharmaceuticals cultivated from living cells ("Grand Experiment," February), is set to be acquired by Pfizer in a $68 billion ...READ MORE›

• Feedback

Digital Matters - Issue 29

In My Humble Opinion: Genomics is the most important economic, political, and ethical issue facing mankind.READ MORE›

Drug Flow and Deal Flow

Biotech Investing Conference November 5-6 Menlo Park, California The news at this year's Biotech Investing confab will focus on Big Pharma companies, as they take a more active role in developing early-stage drugs. ...READ MORE›

The Myelin Repair Foundation Encourages Collaboration for a Cure

Scientists in their labs. Big Pharma in pursuit of the next blockbuster. An innovative foundation brings them together to speed up the discovery of multiple-sclerosis drugs.READ MORE›

Heartburn

If you want an edifying look at how the drug business in this country works, you'd do well to read the article in today's New York Times (registration req'd) about the shortage of Prilosec OTC, the heartburn medication made by Astra ...READ MORE›

Defective Drugs Take Their Toll

Anyone who has been made sick by taking a drug with ghastly side effects knows full well they can take their deadly toll. READ MORE›

No Time to Network

No matter how often we pledge to dedicate more time to develop more meaningful relationships with colleagues and partners, we're still as busy as ever. So how can we build more relationships, when we already have so many things ...READ MORE›

Criminals Who Manufacture Drugs Are Entitled to Defense

There are times in a person's life when the call of millions of dollars is far too strong to resist. Those who choose to manufacture drugs to obtain those millions are still entitled to the finest criminal defense possible.READ MORE›

Most Innovative Companies - Biotech

Sponsored by by Elizabeth ...READ MORE›

Generic Drugs Keep Health Insurance Prices Low

For those wanting to keep their health insurance expenses down, generic drugs are the answer. READ MORE›

CEO See-Ya!

Raymond Gilmartin, CEO of Merck Co.READ MORE›

$5M to Make NYC a Hub for Biotech Startups

San Francisco, Los Angeles, and San Diego are often referred to as the major U.S. biotech hubs. New York City, no longer content to remain king of media and finance, is determined to join the club. To that end, the NYCIF, Henry ...READ MORE›